Nutritional Modulation of Retinopathy in Premature Infants: A Randomized Controlled Trial of Entral Omega-3 Fatty Acids
Journal of Pediatric Medicine and Child Health · 30.06.2026 · 36
DOI: 10.67238/jpch.2026.v2.04 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pediatric Medicine and Child Health, online erschienen am 30.06.2026. Verfasst von Salma Afroz und 2 weiteren Autor:innen.
Themen: Neonatologie
Abstract (Originalsprache)
Background
Retinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness, particularly in low- and middle-income countries. Omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) play a critical role in retinal vascular and neuronal development and may influence the severity of ROP.
Objective
To evaluate the effect of enteral omega-3 LCPUFA supplementation on the incidence and severity of ROP in preterm low-birth-weight infants.
Methods
This randomized controlled trial was conducted at a tertiary care neonatal unit in Bangladesh between June to November 2023. Preterm neonates with gestational age >28 to
Zitieren
APA
Afroz, S., Hoque, M. M., & Saha, L. C. (2026). Nutritional Modulation of Retinopathy in Premature Infants: A Randomized Controlled Trial of Entral Omega-3 Fatty Acids. Journal of Pediatric Medicine and Child Health, 36. https://doi.org/10.67238/jpch.2026.v2.04
Vancouver
Afroz S, Hoque MM, Saha LC. Nutritional Modulation of Retinopathy in Premature Infants: A Randomized Controlled Trial of Entral Omega-3 Fatty Acids. Journal of Pediatric Medicine and Child Health. 2026:36. doi:10.67238/jpch.2026.v2.04
BibTeX
@article{Afroz2026,
author = {Afroz, Salma and Hoque, Md. Mahbubul and Saha, Liton Chandra},
title = {Nutritional Modulation of Retinopathy in Premature Infants: A Randomized Controlled Trial of Entral Omega-3 Fatty Acids},
journal = {Journal of Pediatric Medicine and Child Health},
year = {2026},
pages = {36},
doi = {10.67238/jpch.2026.v2.04}
}
EUVIMED